- Home
- OMDA vs IMTX Comparison
OMDA vs IMTX Comparison
Compare OMDA & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMDA
- IMTX
- Stock Information
- Founded
- OMDA 2011
- IMTX N/A
- Country
- OMDA United States
- IMTX Germany
- Employees
- OMDA N/A
- IMTX N/A
- Industry
- OMDA Medical/Nursing Services
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OMDA Health Care
- IMTX Health Care
- Exchange
- OMDA Nasdaq
- IMTX Nasdaq
- Market Cap
- OMDA 1.3B
- IMTX 1.1B
- IPO Year
- OMDA 2025
- IMTX N/A
- Fundamental
- Price
- OMDA $19.00
- IMTX $10.34
- Analyst Decision
- OMDA Strong Buy
- IMTX Strong Buy
- Analyst Count
- OMDA 9
- IMTX 4
- Target Price
- OMDA $26.44
- IMTX $13.67
- AVG Volume (30 Days)
- OMDA 580.7K
- IMTX 593.1K
- Earning Date
- OMDA 11-06-2025
- IMTX 11-17-2025
- Dividend Yield
- OMDA N/A
- IMTX N/A
- EPS Growth
- OMDA N/A
- IMTX N/A
- EPS
- OMDA N/A
- IMTX N/A
- Revenue
- OMDA $232,342,000.00
- IMTX $99,445,031.00
- Revenue This Year
- OMDA $43.42
- IMTX N/A
- Revenue Next Year
- OMDA $20.01
- IMTX $13.52
- P/E Ratio
- OMDA N/A
- IMTX N/A
- Revenue Growth
- OMDA 89.23
- IMTX N/A
- 52 Week Low
- OMDA $14.14
- IMTX $3.30
- 52 Week High
- OMDA $28.40
- IMTX $11.25
- Technical
- Relative Strength Index (RSI)
- OMDA N/A
- IMTX 56.18
- Support Level
- OMDA N/A
- IMTX $8.92
- Resistance Level
- OMDA N/A
- IMTX $10.86
- Average True Range (ATR)
- OMDA 0.00
- IMTX 0.71
- MACD
- OMDA 0.00
- IMTX -0.03
- Stochastic Oscillator
- OMDA 0.00
- IMTX 75.58
About OMDA Omada Health Inc. Common Stock
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.